Krankenhaushygiene up2date, Table of Contents Krankenhaushygiene up2date 2013; 08(02): 113-125DOI: 10.1055/s-0033-1344340 Antibiotikaanwendung © Georg Thieme Verlag KG Stuttgart · New YorkTuberkulose-Screening und präventive Chemotherapie bei Beschäftigten im Gesundheitswesen Authors Roland Diel Albert Nienhaus Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Full Text References Literatur 1 Robert-Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2011. Berlin: RKI; 2013 2 American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: 221-S247 3 Schaberg T, Bauer T, Castell S et al. [Recommendations for therapy, chemoprevention, and chemoprophylaxis of tuberculosis in adults and children. German Central Committee against Tuberculosis (DZK), German Respiratory Society (DGP)]. Pneumologie 2012; 66: 133-171 4 Diel R et al. Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren bei rheumatischen Erkrankungen. Pneumologie 2009; 63: 329-334 5 Diel R, Goletti D, Ferrara G et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37: 88-99 6 Diel R et al. Neue Empfehlungen des Deutschen Zentralkomitees (DZK) für die Umgebungsuntersuchungen bei Tuberkulose. Pneumologie 2011; 65: 359-378 7 Diel R, Seidler A, Nienhaus A et al. Occupational risk of tuberculosis transmission in a low incidence area. Respir Res 2005; 6: 35-45 8 Nienhaus A, Brandenburg S, Teschler H Hrsg. Tuberkulose als Berufskrankheit – ein Leitfaden zur Begutachtung und Vorsorge. 3.. Aufl. Heidelberg: Ecomed; 2012 9 Torres CJ, Sa R, Cardoso MJ et al. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay. Eur Respir J 2009; 34: 1423-1428 10 Schablon A, Harling M, Diel R et al. Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infect Dis 2010; 10: 107 11 Schablon A, Diel R, Diner G et al. Specificity of a whole blood IGRA in German nursing students. BMC Infect Dis 2011; 11: 245 12 Diel R, Loddenkemper R, Niemann S et al. Negative and positive predictive value of a whole-blood IGRA for developing active TB – an update. Am J Respir Crit Care Med 2011; 183: 88-95 13 Haldar P, Thuraisingam H, Patel H et al. Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk. Thorax 2013; 68: 240-246 14 Nienhaus A, Costa JT. Screening for tuberculosis and the use of a borderlin zone for the interpretation of the interferon-γ release assay (IGRA) in Portuguese healthcare workers. J Occup Med Toxicol 2013; 28: 1 15 Diel R, Loddenkemper R, Meywald-Walter K et al. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot. TB test in contact investigations for tuberculosis. Chest 2009; 135: 1010-1018 16 Ziegler R, Just HM, Castell S et al. Infektionsprävention bei Tuberkulose. Empfehlungen des DZK. Gesundheitswesen 2012; 74: 337-350 17 Smieja MJ, Marchetti CA, Cook DJ et al. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 1999; 1 CD001363 18 Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin- a meta-analysis. Chest 1991; 99: 465-471 19 Thompson NJ. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60: 555-564 20 Kopanoff DE, Snider Jr DE, Caras GJ. Isoniazid-related hepatitis: A U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117: 991-1001 21 Diel R, Nienhaus A. Prevention of TB in areas of low incidence. European Respiratory Society Monograph 2012; 58 : 72-83 22 Sterling TR, Villarino ME, Borisov AS et al. Three months of once-weekly rifapentine and isoniazid for M. tuberculosis infection. N Engl J Med 2011; 365: 2155-2166 23 Martinson NA, Barnes GL, Moulton LH et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011; 365: 11-20 24 Centers for Disease Control and Prevention. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR 2011; 60: 1650-1653 25 Holland DP, Sanders GD, Hamilton CD et al. Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection. Am J Respir Crit Care Med 2009; 179: 1055-1060
